ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Nivolumab in MGMT methylated GBM"
Episode Synopsis
Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.
More episodes of the podcast Neuro-Oncology: The Podcast
A transcriptomic atlas of CNS tumors
11/07/2025
Gut microbiome in primary CNS lymphoma
27/06/2025
Germline analysis of diffuse midline glioma
08/06/2025
Radio-Pathomic maps and MR perfusion
18/04/2025
CSF proteomics in glioma
21/03/2025
Vorasidenib in IDH mutant glioma
08/03/2025
In God we trust